Table 4.
Traditional risk factors and outcomes
| Demographics | n = 37a | % | pEFS | P = |
|---|---|---|---|---|
| Age group | ||||
| Infant group | 12 | 50.00 ± 14.43% | 0.9974 | |
| Noninfant group | 25 | 35.35 ± 11.28% | ||
| Gender | ||||
| Male | 23 | 57.80 ± 12.00% | 0.0160 | |
| Female | 14 | 15.71 ± 10.18% | ||
| WBC count | ||||
| ≥ 50 × 109/L | 25 | 30.03 ± 10.44% | 0.1178 | |
| < 50 × 109/L | 12 | 67.50 ± 15.51% | ||
| ≥ 300 × 109/L | 6 | 16.67 ± 14.83% | 0.0342 | |
| < 300 × 109/L | 31 | 49.57 ± 10.38% | ||
| LDH (U/L) | ||||
| ≥ 2 N | 24 | 32.23 ± 15.06% | 0.1762 | |
| < 2 N | 13 | 45.36 ± 11.07% | ||
| CNSL involvement | ||||
| CNSL- | 35 | 41.95 ± 9.34% | - | |
| CNSL + | 2 | - | ||
| KMT2Ar subtype | ||||
| KMT2A-AFF1 | 16 | 30.00 ± 11.78% | 0.1745 | |
| Non KMT2A-AFF1 | 21 | 51.83 ± 12.88% | ||
| KMT2A-AFF1 | 16 | 30.00 ± 11.78% | 0.4154 | |
| KMT2A-MLLT3 | 11 | 50.00 ± 15.81% | ||
a patients without TRM